APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cas9 Nuclease

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cas9 Nuclease Industry Research Report 2026

28 December 2025130 pages

Choose your research edition.

Industry ResearchCas9 Nuclease Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Cas9 Nuclease Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Cas9 Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cas9 Nuclease Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Cas9 Nuclease Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Cas9 Nuclease market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Cas9 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Cas9 Nuclease is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Cas9 Nuclease is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Cas9 Nuclease include SBS Genetech, Novoprotein, Agilent, Thermo Fisher Scientific, Stemcell Technologies, Sigma-Aldrich, OriGene Technologies, Nippon Gene and New England Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Cas9 Nuclease market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cas9 Nuclease Market by Company

SBS Genetech

Novoprotein

Agilent

Thermo Fisher Scientific

Stemcell Technologies

Sigma-Aldrich

OriGene Technologies

Nippon Gene

New England Biolabs

Kactus

Horizo​​n Discovery

GenScript

Danaher

BPS Bioscience

Applied Biological Materials

Abnova

Cas9 Nuclease Segment by Type

Cas9 mRNA

Cas9 Protein

Cas9 Lentivirus

Cas9 Plasmid

Cas9 Nuclease Segment by Application

Bioagriculture

Gene Therapy

Gene Editing Cell Line Construction

Animal Models

Other

Cas9 Nuclease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cas9 Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cas9 Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cas9 Nuclease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cas9 Nuclease manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cas9 Nuclease by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cas9 Nuclease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cas9 Nuclease Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cas9 Nuclease Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Cas9 Nuclease Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cas9 Nuclease Revenue of Manufacturers (2021-2026) Table 9. Global Cas9 Nuclease Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cas9 Nuclease Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Cas9 Nuclease Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cas9 Nuclease, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cas9 Nuclease, Product Type & Application Table 14. Global Cas9 Nuclease Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cas9 Nuclease by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. SBS Genetech Company Information Table 19. SBS Genetech Business Overview Table 20. SBS Genetech Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. SBS Genetech Cas9 Nuclease Product Portfolio Table 22. SBS Genetech Recent Developments Table 23. Novoprotein Company Information Table 24. Novoprotein Business Overview Table 25. Novoprotein Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Novoprotein Cas9 Nuclease Product Portfolio Table 27. Novoprotein Recent Developments Table 28. Agilent Company Information Table 29. Agilent Business Overview Table 30. Agilent Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Agilent Cas9 Nuclease Product Portfolio Table 32. Agilent Recent Developments Table 33. Thermo Fisher Scientific Company Information Table 34. Thermo Fisher Scientific Business Overview Table 35. Thermo Fisher Scientific Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Thermo Fisher Scientific Cas9 Nuclease Product Portfolio Table 37. Thermo Fisher Scientific Recent Developments Table 38. Stemcell Technologies Company Information Table 39. Stemcell Technologies Business Overview Table 40. Stemcell Technologies Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Stemcell Technologies Cas9 Nuclease Product Portfolio Table 42. Stemcell Technologies Recent Developments Table 43. Sigma-Aldrich Company Information Table 44. Sigma-Aldrich Business Overview Table 45. Sigma-Aldrich Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Sigma-Aldrich Cas9 Nuclease Product Portfolio Table 47. Sigma-Aldrich Recent Developments Table 48. OriGene Technologies Company Information Table 49. OriGene Technologies Business Overview Table 50. OriGene Technologies Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. OriGene Technologies Cas9 Nuclease Product Portfolio Table 52. OriGene Technologies Recent Developments Table 53. Nippon Gene Company Information Table 54. Nippon Gene Business Overview Table 55. Nippon Gene Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Nippon Gene Cas9 Nuclease Product Portfolio Table 57. Nippon Gene Recent Developments Table 58. New England Biolabs Company Information Table 59. New England Biolabs Business Overview Table 60. New England Biolabs Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. New England Biolabs Cas9 Nuclease Product Portfolio Table 62. New England Biolabs Recent Developments Table 63. Kactus Company Information Table 64. Kactus Business Overview Table 65. Kactus Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Kactus Cas9 Nuclease Product Portfolio Table 67. Kactus Recent Developments Table 68. Horizo​​n Discovery Company Information Table 69. Horizo​​n Discovery Business Overview Table 70. Horizo​​n Discovery Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Horizo​​n Discovery Cas9 Nuclease Product Portfolio Table 72. Horizo​​n Discovery Recent Developments Table 73. GenScript Company Information Table 74. GenScript Business Overview Table 75. GenScript Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GenScript Cas9 Nuclease Product Portfolio Table 77. GenScript Recent Developments Table 78. Danaher Company Information Table 79. Danaher Business Overview Table 80. Danaher Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Danaher Cas9 Nuclease Product Portfolio Table 82. Danaher Recent Developments Table 83. BPS Bioscience Company Information Table 84. BPS Bioscience Business Overview Table 85. BPS Bioscience Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. BPS Bioscience Cas9 Nuclease Product Portfolio Table 87. BPS Bioscience Recent Developments Table 88. Applied Biological Materials Company Information Table 89. Applied Biological Materials Business Overview Table 90. Applied Biological Materials Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Applied Biological Materials Cas9 Nuclease Product Portfolio Table 92. Applied Biological Materials Recent Developments Table 93. Abnova Company Information Table 94. Abnova Business Overview Table 95. Abnova Cas9 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Abnova Cas9 Nuclease Product Portfolio Table 97. Abnova Recent Developments Table 98. Global Cas9 Nuclease Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Cas9 Nuclease Sales by Region (2021-2026) & (K Units) Table 100. Global Cas9 Nuclease Sales Market Share by Region (2021-2026) Table 101. Global Cas9 Nuclease Sales by Region (2027-2032) & (K Units) Table 102. Global Cas9 Nuclease Sales Market Share by Region (2027-2032) Table 103. Global Cas9 Nuclease Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Cas9 Nuclease Revenue Market Share by Region (2021-2026) Table 105. Global Cas9 Nuclease Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Cas9 Nuclease Revenue Market Share by Region (2027-2032) Table 107. North America Cas9 Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 109. North America Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 110. North America Cas9 Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Cas9 Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Cas9 Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 114. Europe Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 115. Europe Cas9 Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Cas9 Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Cas9 Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 119. Asia Pacific Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 120. Asia Pacific Cas9 Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Cas9 Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Cas9 Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 124. South America Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 125. South America Cas9 Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Cas9 Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Cas9 Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Cas9 Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Cas9 Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Cas9 Nuclease Sales by Type (2021-2026) & (K Units) Table 133. Global Cas9 Nuclease Sales by Type (2027-2032) & (K Units) Table 134. Global Cas9 Nuclease Sales Market Share by Type (2021-2026) Table 135. Global Cas9 Nuclease Sales Market Share by Type (2027-2032) Table 136. Global Cas9 Nuclease Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Cas9 Nuclease Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Cas9 Nuclease Revenue Market Share by Type (2021-2026) Table 139. Global Cas9 Nuclease Revenue Market Share by Type (2027-2032) Table 140. Global Cas9 Nuclease Price by Type (2021-2026) & (US$/Unit) Table 141. Global Cas9 Nuclease Price by Type (2027-2032) & (US$/Unit) Table 142. Global Cas9 Nuclease Sales by Application (2021-2026) & (K Units) Table 143. Global Cas9 Nuclease Sales by Application (2027-2032) & (K Units) Table 144. Global Cas9 Nuclease Sales Market Share by Application (2021-2026) Table 145. Global Cas9 Nuclease Sales Market Share by Application (2027-2032) Table 146. Global Cas9 Nuclease Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Cas9 Nuclease Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Cas9 Nuclease Revenue Market Share by Application (2021-2026) Table 149. Global Cas9 Nuclease Revenue Market Share by Application (2027-2032) Table 150. Global Cas9 Nuclease Price by Application (2021-2026) & (US$/Unit) Table 151. Global Cas9 Nuclease Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Cas9 Nuclease Distributors List Table 155. Cas9 Nuclease Customers List Table 156. Cas9 Nuclease Industry Trends Table 157. Cas9 Nuclease Industry Drivers Table 158. Cas9 Nuclease Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cas9 Nuclease Product Image Figure 5. Global Cas9 Nuclease Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cas9 Nuclease Market Size (2021-2032) & (US$ Million) Figure 7. Global Cas9 Nuclease Sales (2021-2032) & (K Units) Figure 8. Global Cas9 Nuclease Average Price (US$/Unit) & (2021-2032) Figure 9. Cas9 mRNA Product Image Figure 10. Cas9 Protein Product Image Figure 11. Cas9 Lentivirus Product Image Figure 12. Cas9 Plasmid Product Image Figure 13. Bioagriculture Product Image Figure 14. Gene Therapy Product Image Figure 15. Gene Editing Cell Line Construction Product Image Figure 16. Animal Models Product Image Figure 17. Other Product Image Figure 18. Global Cas9 Nuclease Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Cas9 Nuclease, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Cas9 Nuclease Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Cas9 Nuclease Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Cas9 Nuclease Sales by Region in 2025 Figure 24. Global Cas9 Nuclease Revenue by Region in 2025 Figure 25. North America Cas9 Nuclease Market Size by Country in 2025 Figure 26. North America Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 27. North America Cas9 Nuclease Revenue Market Share by Country (2021-2032) Figure 28. United States Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Cas9 Nuclease Market Size by Country in 2025 Figure 32. Europe Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 33. Europe Cas9 Nuclease Revenue Market Share by Country (2021-2032) Figure 34. Germany Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Cas9 Nuclease Market Size by Country in 2025 Figure 45. Asia Pacific Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Cas9 Nuclease Revenue Market Share by Country (2021-2032) Figure 47. China Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Cas9 Nuclease Market Size by Country in 2025 Figure 56. South America Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 57. South America Cas9 Nuclease Revenue Market Share by Country (2021-2032) Figure 58. Brazil Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Cas9 Nuclease Market Size by Country in 2025 Figure 62. Middle East and Africa Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Cas9 Nuclease Revenue Market Share by Country (2021-2032) Figure 64. Egypt Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Cas9 Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Cas9 Nuclease Sales Market Share by Type (2021-2032) Figure 70. Global Cas9 Nuclease Revenue Market Share by Type (2021-2032) Figure 71. Global Cas9 Nuclease Price (US$/Unit) by Type (2021-2032) Figure 72. Global Cas9 Nuclease Sales Market Share by Application (2021-2032) Figure 73. Global Cas9 Nuclease Revenue Market Share by Application (2021-2032) Figure 74. Global Cas9 Nuclease Price (US$/Unit) by Application (2021-2032) Figure 75. Cas9 Nuclease Value Chain Figure 76. Cas9 Nuclease Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Cas9 Nuclease Industry Opportunities and Challenges

Scope & coverage.

Types
  • Cas9 mRNA
  • Cas9 Protein
  • Cas9 Lentivirus
  • Cas9 Plasmid
Applications
  • Bioagriculture
  • Gene Therapy
  • Gene Editing Cell Line Construction
  • Animal Models
  • Other
Companies covered
  • SBS Genetech
  • Novoprotein
  • Agilent
  • Thermo Fisher Scientific
  • Stemcell Technologies
  • Sigma-Aldrich
  • OriGene Technologies
  • Nippon Gene
  • New England Biolabs
  • Kactus
  • Horizo​​n Discovery
  • GenScript
  • Danaher
  • BPS Bioscience
  • Applied Biological Materials
  • Abnova

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cas9 Nuclease Market Size (2021-2032)
  4. 2.2.2 Global Cas9 Nuclease Sales (2021-2032)
  5. 2.2.3 Global Cas9 Nuclease Market Average Price (2021-2032)
  6. 2.3 Cas9 Nuclease by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Cas9 mRNA
  9. 2.3.3 Cas9 Protein
  10. 2.3.4 Cas9 Lentivirus
  11. 2.3.5 Cas9 Plasmid
  12. 2.4 Cas9 Nuclease by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Bioagriculture
  15. 2.4.3 Gene Therapy
  16. 2.4.4 Gene Editing Cell Line Construction
  17. 2.4.5 Animal Models
  18. 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cas9 Nuclease Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cas9 Nuclease Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Cas9 Nuclease Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cas9 Nuclease Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cas9 Nuclease Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cas9 Nuclease, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cas9 Nuclease, Product Type & Application
  8. 3.8 Global Manufacturers of Cas9 Nuclease, Established Date
  9. 3.9 Global Cas9 Nuclease Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 SBS Genetech
  2. 4.1.1 SBS Genetech Company Information
  3. 4.1.2 SBS Genetech Business Overview
  4. 4.1.3 SBS Genetech Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 SBS Genetech Cas9 Nuclease Product Portfolio
  6. 4.1.5 SBS Genetech Recent Developments
  7. 4.2 Novoprotein
  8. 4.2.1 Novoprotein Company Information
  9. 4.2.2 Novoprotein Business Overview
  10. 4.2.3 Novoprotein Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novoprotein Cas9 Nuclease Product Portfolio
  12. 4.2.5 Novoprotein Recent Developments
  13. 4.3 Agilent
  14. 4.3.1 Agilent Company Information
  15. 4.3.2 Agilent Business Overview
  16. 4.3.3 Agilent Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Agilent Cas9 Nuclease Product Portfolio
  18. 4.3.5 Agilent Recent Developments
  19. 4.4 Thermo Fisher Scientific
  20. 4.4.1 Thermo Fisher Scientific Company Information
  21. 4.4.2 Thermo Fisher Scientific Business Overview
  22. 4.4.3 Thermo Fisher Scientific Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Thermo Fisher Scientific Cas9 Nuclease Product Portfolio
  24. 4.4.5 Thermo Fisher Scientific Recent Developments
  25. 4.5 Stemcell Technologies
  26. 4.5.1 Stemcell Technologies Company Information
  27. 4.5.2 Stemcell Technologies Business Overview
  28. 4.5.3 Stemcell Technologies Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Stemcell Technologies Cas9 Nuclease Product Portfolio
  30. 4.5.5 Stemcell Technologies Recent Developments
  31. 4.6 Sigma-Aldrich
  32. 4.6.1 Sigma-Aldrich Company Information
  33. 4.6.2 Sigma-Aldrich Business Overview
  34. 4.6.3 Sigma-Aldrich Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sigma-Aldrich Cas9 Nuclease Product Portfolio
  36. 4.6.5 Sigma-Aldrich Recent Developments
  37. 4.7 OriGene Technologies
  38. 4.7.1 OriGene Technologies Company Information
  39. 4.7.2 OriGene Technologies Business Overview
  40. 4.7.3 OriGene Technologies Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 OriGene Technologies Cas9 Nuclease Product Portfolio
  42. 4.7.5 OriGene Technologies Recent Developments
  43. 4.8 Nippon Gene
  44. 4.8.1 Nippon Gene Company Information
  45. 4.8.2 Nippon Gene Business Overview
  46. 4.8.3 Nippon Gene Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Nippon Gene Cas9 Nuclease Product Portfolio
  48. 4.8.5 Nippon Gene Recent Developments
  49. 4.9 New England Biolabs
  50. 4.9.1 New England Biolabs Company Information
  51. 4.9.2 New England Biolabs Business Overview
  52. 4.9.3 New England Biolabs Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 New England Biolabs Cas9 Nuclease Product Portfolio
  54. 4.9.5 New England Biolabs Recent Developments
  55. 4.10 Kactus
  56. 4.10.1 Kactus Company Information
  57. 4.10.2 Kactus Business Overview
  58. 4.10.3 Kactus Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Kactus Cas9 Nuclease Product Portfolio
  60. 4.10.5 Kactus Recent Developments
  61. 4.11 Horizo​​n Discovery
  62. 4.11.1 Horizo​​n Discovery Company Information
  63. 4.11.2 Horizo​​n Discovery Business Overview
  64. 4.11.3 Horizo​​n Discovery Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Horizo​​n Discovery Cas9 Nuclease Product Portfolio
  66. 4.11.5 Horizo​​n Discovery Recent Developments
  67. 4.12 GenScript
  68. 4.12.1 GenScript Company Information
  69. 4.12.2 GenScript Business Overview
  70. 4.12.3 GenScript Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 GenScript Cas9 Nuclease Product Portfolio
  72. 4.12.5 GenScript Recent Developments
  73. 4.13 Danaher
  74. 4.13.1 Danaher Company Information
  75. 4.13.2 Danaher Business Overview
  76. 4.13.3 Danaher Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Danaher Cas9 Nuclease Product Portfolio
  78. 4.13.5 Danaher Recent Developments
  79. 4.14 BPS Bioscience
  80. 4.14.1 BPS Bioscience Company Information
  81. 4.14.2 BPS Bioscience Business Overview
  82. 4.14.3 BPS Bioscience Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 BPS Bioscience Cas9 Nuclease Product Portfolio
  84. 4.14.5 BPS Bioscience Recent Developments
  85. 4.15 Applied Biological Materials
  86. 4.15.1 Applied Biological Materials Company Information
  87. 4.15.2 Applied Biological Materials Business Overview
  88. 4.15.3 Applied Biological Materials Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Applied Biological Materials Cas9 Nuclease Product Portfolio
  90. 4.15.5 Applied Biological Materials Recent Developments
  91. 4.16 Abnova
  92. 4.16.1 Abnova Company Information
  93. 4.16.2 Abnova Business Overview
  94. 4.16.3 Abnova Cas9 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Abnova Cas9 Nuclease Product Portfolio
  96. 4.16.5 Abnova Recent Developments
5 Global Cas9 Nuclease Market Scenario by Region
  1. 5.1 Global Cas9 Nuclease Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cas9 Nuclease Sales by Region: 2021-2032
  3. 5.2.1 Global Cas9 Nuclease Sales by Region: 2021-2026
  4. 5.2.2 Global Cas9 Nuclease Sales by Region: 2027-2032
  5. 5.3 Global Cas9 Nuclease Revenue by Region: 2021-2032
  6. 5.3.1 Global Cas9 Nuclease Revenue by Region: 2021-2026
  7. 5.3.2 Global Cas9 Nuclease Revenue by Region: 2027-2032
  8. 5.4 North America Cas9 Nuclease Market Facts & Figures by Country
  9. 5.4.1 North America Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cas9 Nuclease Sales by Country (2021-2032)
  11. 5.4.3 North America Cas9 Nuclease Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Cas9 Nuclease Market Facts & Figures by Country
  16. 5.5.1 Europe Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Cas9 Nuclease Sales by Country (2021-2032)
  18. 5.5.3 Europe Cas9 Nuclease Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Cas9 Nuclease Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Cas9 Nuclease Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Cas9 Nuclease Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Cas9 Nuclease Market Facts & Figures by Country
  41. 5.7.1 South America Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Cas9 Nuclease Sales by Country (2021-2032)
  43. 5.7.3 South America Cas9 Nuclease Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Cas9 Nuclease Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Cas9 Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Cas9 Nuclease Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Cas9 Nuclease Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Cas9 Nuclease Sales by Type (2021-2032)
  2. 6.1.1 Global Cas9 Nuclease Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Cas9 Nuclease Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cas9 Nuclease Revenue by Type (2021-2032)
  5. 6.2.1 Global Cas9 Nuclease Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cas9 Nuclease Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cas9 Nuclease Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cas9 Nuclease Sales by Application (2021-2032)
  2. 7.1.1 Global Cas9 Nuclease Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Cas9 Nuclease Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cas9 Nuclease Revenue by Application (2021-2032)
  5. 7.2.1 Global Cas9 Nuclease Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cas9 Nuclease Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cas9 Nuclease Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cas9 Nuclease Value Chain Analysis
  2. 8.1.1 Cas9 Nuclease Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cas9 Nuclease Production Mode & Process
  5. 8.2 Cas9 Nuclease Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cas9 Nuclease Distributors
  8. 8.2.3 Cas9 Nuclease Customers
9 Global Cas9 Nuclease Analyzing Market Dynamics
  1. 9.1 Cas9 Nuclease Industry Trends
  2. 9.2 Cas9 Nuclease Industry Drivers
  3. 9.3 Cas9 Nuclease Industry Opportunities and Challenges
  4. 9.4 Cas9 Nuclease Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst